With a combined industry experience of more than 40 years, TRI’s management team has the capability and desire to ensure that both our client’s needs and TRI’s business objectives are met with every engagement.
Founder and CEO - Duncan Hall
Duncan has over fifteen years of consultancy experience, thirteen of which have been within clinical R&D in both CRO and Pharma businesses. Duncan started Triumph in 2002 with the aim of building a global business which would be focused in improving the delivery, quality and value of clinical systems. Duncan now takes a primarily strategic role in TRI, but still performs client delivery roles where possible.
COO -Tammy Finnigan
Tammy has 20 years clinical research experience, having worked in both large Pharma and large CRO companies prior to joining TRI. Her experience both in monitoring, and managing clinical trials have provided valuable insight the way quality management processes and supporting tools should work. Tammy is the business sponsor of TRIs RBM tool, OPRA and is actively involved in supporting multiple RBM projects with TRI clients. For almost 4 years, Tammy has been working with the MCC as a representative on the Risk Based Monitoring and Central Monitoring working groups.
With more than twenty years of consultancy experience, Neil has been instrumental in the successful growth and development of a number of professional services organisations. Previous roles include the Finance Director for a UK based change, project and program management consultancy. Neil was instrumental in the creation and set-up of TRI.